Citation Impact
Citing Papers
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism
2015 Nobel
Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview
2014
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
2012
Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
2011
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Population History and Natural Selection Shape Patterns of Genetic Variation in 132 Genes
2004
Brain Ferritin Iron as a Risk Factor for Age at Onset in Neurodegenerative Diseases
2004
Parkinson's disease
2021 Standout
The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease
2010
The −1082G/A polymorphism in IL-10 gene is associated with risk of Alzheimer's disease: A meta-analysis
2011
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
The role of autophagy in neurodegenerative disease
2013 Standout
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Myeloperoxidase G-463A polymorphism and Alzheimer's disease in the ApoEurope study
2003
Alzheimer's disease
2011 Standout
Glycogen synthase kinase‐3β and tau genes interact in Alzheimer's disease
2008
Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
2008
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
Guillain-Barré syndrome
2016 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Microglial cell origin and phenotypes in health and disease
2011 Standout
Toll-Like Receptor 2 Acts as a Natural Innate Immune Receptor to Clear Amyloid β1–42and Delay the Cognitive Decline in a Mouse Model of Alzheimer's Disease
2008
Inflammation, Depression and Dementia: Are they Connected?
2007
The Molecular Genetics of Crop Domestication
2006 Standout
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex
2014 Standout
Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism
2016 Standout
Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease
2003
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Antibody therapy of cancer
2012 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Toll-Like Receptors in Alzheimer's Disease
2009
Neutrophils and immunity: challenges and opportunities
2006 Standout
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
The Rise and Fall of the Chemoattractant Receptor GPR33
2005 StandoutNobel
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
2008
Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
2007
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
2009 Standout
Role and Therapeutic Potential of VEGF in the Nervous System
2009
Parkinson's disease
2015 Standout
A Meta-Analysis of Cytokines in Alzheimer's Disease
2010
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
2013 Standout
Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration
2006
Long-term intracerebral inflammatory response after traumatic brain injury
2004
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Alzheimer's disease
2006 Standout
Alzheimer's disease
2016 Standout
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease
2011 Standout
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
Sporadic adult onset ataxia of unknown etiology
2007
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Major Depressive Disorder
2008 Standout
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-1 and receptor-2 agonists for cancer therapy
2009
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Meta-analysis of serotonin transporter polymorphisms and affective disorders
2004
Interleukin-6, a mental cytokine
2011
The ups and downs of Wnt signaling in prevalent neurological disorders
2006
Vascular endothelial growth factor: a neurovascular target in neurological diseases
2016
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies
2008
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
2008 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
Interleukin-6 −174G/C polymorphism and the risk of Alzheimer's disease in Caucasians: A meta-analysis
2011
Selective liver X receptor modulators (SLiMs): What use in human health?
2011
Regulation of innate immune responses in the brain
2009
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains
2009
Genetic Variants in the RAB7L1 and SLC41A1 Genes of the PARK16 Locus in Chinese Parkinson's Disease Patients
2011
Mitochondrial cardiomyopathies: how to identify candidate pathogenic mutations by mitochondrial DNA sequencing, MITOMASTER and phylogeny
2010
Prospective study of plasma urate and risk of Parkinson disease in men and women
2016
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer's Disease Detected in vivo with Magnetic Resonance Imaging
2013
Magnesium in Man: Implications for Health and Disease
2014 Standout
Current concepts in the diagnosis and management of cytokine release syndrome
2014 Standout
Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity
2013
Plasma urate and risk of Parkinson's disease: A mendelian randomization study
2018
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
2015
Metabolic control of cell death
2014 Science
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation
2013
A Double-Edged Sword: The Role of VEGF in Wound Repair and Chemoattraction of Opportunist Pathogens
2015
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Mendelian randomization of serum urate and parkinson disease progression
2014
Clinical Features of Friedreich Ataxia
2012
Claudins and the Modulation of Tight Junction Permeability
2013 Standout
Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet
2011 StandoutNobel
Clinical features of Friedreich's ataxia: classical and atypical phenotypes
2013
Second consensus statement on the diagnosis of multiple system atrophy
2008 Standout
Vascular endothelial growth factor gene variability is associated with increased risk for AD
2005
Myeloperoxidase: friend and foe
2005 Standout
Metals in Neurobiology: Probing Their Chemistry and Biology with Molecular Imaging
2008 Standout
Physiology of Microglia
2011 Standout
Spinal nerve involvement in early Guillain–Barré syndrome: A clinico-electrophysiological, ultrasonographic and pathological study
2014
Works of Jon Infante being referenced
Interleukin‐1A (−889) genetic polymorphism increases the risk of multiple system atrophy
2003
Lrrk2 R1441G-related Parkinson’s disease: evidence of a common founding event in the seventh century in Northern Spain
2009
Magnetic resonance imaging of lower limb musculature in acute motor axonal neuropathy
2011
Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease
2006
Low serum VEGF levels are associated with Alzheimer's disease
2006
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
2005
Association between Glycogen Synthase Kinase-3β Genetic Polymorphism and Late-Onset Alzheimer’s Disease
2006
Gene–gene interaction between heme oxygenase-1 and liver X receptor-β and Alzheimer's disease risk
2008
Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer’s disease risk
2008
Interaction between CD14 and LXRβ genes modulates Alzheimer's disease risk
2007
Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease
2002
Very late‐onset Friedreich's ataxia with minimal GAA1 expansion mimicking multiple system atrophy of cerebellar type
2005
SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V
2012
No synergistic effect between −850 tumor necrosis factor-α promoter polymorphism and apolipoprotein E ε4 allele in Alzheimer's disease
2002
Inflammation‐related genes and the risk of Parkinson’s disease: a multilocus approach
2008
The chemokine receptor CCR5-Δ32 gene mutation is not protective against Alzheimer’s disease
2004
Replication of MAPT and SNCA, but not PARK16‐18, as susceptibility genes for Parkinson's disease
2011
Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-α gene polymorphisms and the risk for multiple system atrophy
2004
CD14 receptor polymorphism and Alzheimer's disease risk
2005
Serum levels and genetic variation of TGF-β1 are not associated with Alzheimer’s disease
2007
The myeloperoxidase gene in Alzheimer's disease: a case-control study and meta-analysis
2002
No evidence for association of the monocyte chemoattractant protein-1 (−2518) gene polymorphism and Alzheimer's disease
2004
Candidate Gene Association Studies in Sporadic Alzheimer’s Disease
2002
Interaction between Poly(ADP-Ribose) Polymerase 1 and Interleukin 1A Genes Is Associated with Alzheimer’s Disease Risk
2007
Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease
2001
Synergistic effect of two oxidative stress‐related genes (heme oxygenase‐1 and GSK3β) on the risk of Parkinson’s disease
2009
Interaction of the H63D Mutation in the Hemochromatosis Gene with the Apolipoprotein E Epsilon 4 Allele Modulates Age at Onset of Alzheimer’s Disease
2003
Progressive cardiomyopathy as manifestation of mitochondrial disease
2002
A phase Ib/II trial of AMG 655 and panitumumab (pmab) for the treatment (tx) of metastatic colorectal cancer (mCRC): Safety results
2009
Severe Serotonin Syndrome Induced by Mirtazapine Monotherapy
2002
Genetic variability related to serum uric acid concentration and risk of Parkinson's disease
2013
Gene–gene interaction between interleukin-6 and interleukin-10 reduces AD risk
2004
Safety and efficacy of AMG 655 plus modified FOLFOX6 (mFOLFOX6) and bevacizumab (B) for the first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
2009
Serum heme oxygenase-1 levels are increased in Parkinsonâs disease but not in Alzheimerâs disease
2009
Celiac disease and idiopathic cerebellar ataxia
2000